Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if Revlimid (lenalidomide) can help to
reduce the level of leukemia in your body. The safety of this drug will also be studied.